3-120709787-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_173825.5(RABL3):c.261C>T(p.Ser87=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00561 in 1,607,196 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0041 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0058 ( 38 hom. )
Consequence
RABL3
NM_173825.5 synonymous
NM_173825.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.157
Genes affected
RABL3 (HGNC:18072): (RAB, member of RAS oncogene family like 3) Predicted to enable GTP binding activity; GTPase activity; and protein homodimerization activity. Involved in regulation of Ras protein signal transduction and regulation of protein lipidation. Predicted to be active in endomembrane system. Implicated in pancreatic cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 3-120709787-G-A is Benign according to our data. Variant chr3-120709787-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2654061.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.157 with no splicing effect.
BS2
High AC in GnomAd4 at 617 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABL3 | NM_173825.5 | c.261C>T | p.Ser87= | synonymous_variant | 3/8 | ENST00000273375.8 | NP_776186.2 | |
RABL3 | NM_001363965.1 | c.261C>T | p.Ser87= | synonymous_variant | 3/9 | NP_001350894.1 | ||
RABL3 | NM_001363964.1 | c.261C>T | p.Ser87= | synonymous_variant | 3/7 | NP_001350893.1 | ||
RABL3 | NR_157022.1 | n.575C>T | non_coding_transcript_exon_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABL3 | ENST00000273375.8 | c.261C>T | p.Ser87= | synonymous_variant | 3/8 | 1 | NM_173825.5 | ENSP00000273375 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00406 AC: 617AN: 151982Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
617
AN:
151982
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00414 AC: 1023AN: 247112Hom.: 4 AF XY: 0.00412 AC XY: 551AN XY: 133674
GnomAD3 exomes
AF:
AC:
1023
AN:
247112
Hom.:
AF XY:
AC XY:
551
AN XY:
133674
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00577 AC: 8399AN: 1455096Hom.: 38 Cov.: 29 AF XY: 0.00562 AC XY: 4072AN XY: 724006
GnomAD4 exome
AF:
AC:
8399
AN:
1455096
Hom.:
Cov.:
29
AF XY:
AC XY:
4072
AN XY:
724006
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00406 AC: 617AN: 152100Hom.: 2 Cov.: 32 AF XY: 0.00394 AC XY: 293AN XY: 74350
GnomAD4 genome
AF:
AC:
617
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
293
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | RABL3: BP4, BP7, BS2 - |
RABL3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 16, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at